| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-20 | 2009-09-30 | N-Q | Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund | Small-Cap Core | | Sold All | -12,310 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | 639,621 | Sold Some | -7,319 | -1.13 % | $5,724,608 | $5,564,703 | $-159,905 | -2.79 % | $1,830 | | | | | | News Article | History of Amvescap Plc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | 23,841 | Sold Some | -27,571 | -53.62 % | $213,377 | $207,417 | $-5,960 | -2.79 % | $6,893 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | 2,000 | New Holding | 2,000 | 100 % | $17,900 | $17,400 | $-500 | -2.79 % | $-500 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | American International Group Inc | Institution | 19,915 | No Change | 0 | 0 % | $181,027 | $173,261 | $-7,767 | -4.29 % | $0 | | | | | | News Article | History of American International Group Inc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Argyll Research Llc | Institution | 250,000 | New Holding | 250,000 | 100 % | $2,272,500 | $2,175,000 | $-97,500 | -4.29 % | $-97,500 | | | | | | News Article | History of Argyll Research Llc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Black River Asset Management Llc | Institution | | Sold All | -9,239 | -100 % | | | | -4.29 % | $3,603 | | | | | | News Article | History of Black River Asset Management Llc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | 10,996 | Sold Some | -108,958 | -90.83 % | $99,954 | $95,665 | $-4,288 | -4.29 % | $42,494 | | | | | | News Article | History of Citadel L P Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fmr Corp | Institution | 7,563,984 | Added More | 3,418 | 0.04 % | $68,756,615 | $65,806,661 | $-2,949,954 | -4.29 % | $-1,333 | | | | | | News Article | History of Fmr Corp Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Galleon Management L P | Institution | | Sold All | -30,000 | -100 % | | | | -4.29 % | $11,700 | | | | | | News Article | History of Galleon Management L P Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ing Groep Nv | Institution | 10,730 | New Holding | 10,730 | 100 % | $97,536 | $93,351 | $-4,185 | -4.29 % | $-4,185 | | | | | | News Article | History of Ing Groep Nv Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Leuthold Weeden Capital Management Llc | Institution | 224,874 | New Holding | 224,874 | 100 % | $2,044,105 | $1,956,404 | $-87,701 | -4.29 % | $-87,701 | | | | | | News Article | History of Leuthold Weeden Capital Management Llc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Millennium Management Llc | Institution | 53,170 | Added More | 36,012 | 209.88 % | $483,315 | $462,579 | $-20,736 | -4.29 % | $-14,045 | | | | | | News Article | History of Millennium Management Llc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 18,122 | Added More | 2,204 | 13.84 % | $164,729 | $157,661 | $-7,068 | -4.29 % | $-860 | | | | | | News Article | History of Morgan Stanley Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 297,766 | Added More | 20,440 | 7.37 % | $2,706,693 | $2,590,564 | $-116,129 | -4.29 % | $-7,972 | | | | | | News Article | History of Northern Trust Corp Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Oppenheimer Funds Inc | Institution | 59,607 | Added More | 41,027 | 220.81 % | $541,828 | $518,581 | $-23,247 | -4.29 % | $-16,001 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Orbimed Advisors Llc | Institution | | Sold All | -129,634 | -100 % | | | | -4.29 % | $50,557 | | | | | | News Article | History of Orbimed Advisors Llc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Perceptive Advisors Llc | Institution | 450,000 | New Holding | 450,000 | 100 % | $4,090,500 | $3,915,000 | $-175,500 | -4.29 % | $-175,500 | | | | | | News Article | History of Perceptive Advisors Llc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Sac Capital Advisors Lp | No Data | 501,840 | Sold Some | -247,242 | -33.00 % | $4,561,726 | $4,366,008 | $-195,718 | -4.29 % | $96,424 | | | | | | News Article | History of Sac Capital Advisors Lp Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Shaw D E And Co Inc | Institution | | Sold All | -23,830 | -100 % | | | | -4.29 % | $9,294 | | | | | | News Article | History of Shaw D E And Co Inc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 1,901 | No Change | 0 | 0 % | $17,280 | $16,539 | $-741 | -4.29 % | $0 | | | | | | News Article | History of Us Bancorp De Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Weiss Multi-Strategy Advisers Llc | Institution | 85,000 | Added More | 27,600 | 48.08 % | $772,650 | $739,500 | $-33,150 | -4.29 % | $-10,764 | | | | | | News Article | History of Weiss Multi-Strategy Advisers Llc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wellington Management Co Llp | Institution | 737,473 | Added More | 59,673 | 8.80 % | $6,703,630 | $6,416,015 | $-287,614 | -4.29 % | $-23,272 | | | | | | News Article | History of Wellington Management Co Llp Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Axa | Institution | 49,051 | Sold Some | -12,349 | -20.11 % | $447,345 | $426,744 | $-20,601 | -4.60 % | $5,187 | | | | | | News Article | History of Axa Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 37,857 | Added More | 19,342 | 104.46 % | $345,256 | $329,356 | $-15,900 | -4.60 % | $-8,124 | | | | | | News Article | History of Barclays Plc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Dnb Asset Management Us Inc | Institution | | Sold All | -58,619 | -100 % | | | | -4.60 % | $24,620 | | | | | | News Article | History of Dnb Asset Management Us Inc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Gartmore Mutual Fund Capital Trust | Institution | 250 | Sold Some | -18,250 | -98.64 % | $2,280 | $2,175 | $-105 | -4.60 % | $7,665 | | | | | | News Article | History of Gartmore Mutual Fund Capital Trust Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 84,610 | Added More | 11,563 | 15.82 % | $771,643 | $736,107 | $-35,536 | -4.60 % | $-4,856 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 317,115 | Added More | 255,549 | 415.08 % | $2,892,089 | $2,758,901 | $-133,188 | -4.60 % | $-107,331 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Independence Capital Asset Partners Llc | Institution | 371,458 | Added More | 36,896 | 11.02 % | $3,387,697 | $3,231,685 | $-156,012 | -4.60 % | $-15,496 | | | | | | News Article | History of Independence Capital Asset Partners Llc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Knight Capital Group Inc | Institution | 11,917 | New Holding | 11,917 | 100 % | $108,683 | $103,678 | $-5,005 | -4.60 % | $-5,005 | | | | | | News Article | History of Knight Capital Group Inc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Price T Rowe Associates Inc | Institution | 2,721,266 | Sold Some | -437,368 | -13.84 % | $24,817,946 | $23,675,014 | $-1,142,932 | -4.60 % | $183,695 | | | | | | News Article | History of Price T Rowe Associates Inc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 3,929 | Added More | 3,568 | 988.36 % | $35,832 | $34,182 | $-1,650 | -4.60 % | $-1,499 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 919,086 | Added More | 190,453 | 26.13 % | $8,382,064 | $7,996,048 | $-386,016 | -4.60 % | $-79,990 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-12 | 2009-10-30 | 13F-HR | Td Asset Management Inc | Institution | 44,900 | Sold Some | -22,100 | -32.98 % | $428,795 | $390,630 | $-38,165 | -8.90 % | $18,785 | | | | | | News Article | History of Td Asset Management Inc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 1,198,525 | Added More | 118,686 | 10.99 % | $11,445,914 | $10,427,168 | $-1,018,746 | -8.90 % | $-100,883 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bbt Capital Management Inc | Institution | | Sold All | -270,000 | -100 % | | | | -8.90 % | $229,500 | | | | | | News Article | History of Bbt Capital Management Inc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Credit Suisse | Institution | 9,605 | New Holding | 9,605 | 100 % | $91,728 | $83,564 | $-8,164 | -8.90 % | $-8,164 | | | | | | News Article | History of Credit Suisse Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Franklin Resources Inc | Institution | 752,868 | Sold Some | -134,231 | -15.13 % | $7,189,889 | $6,549,952 | $-639,938 | -8.90 % | $114,096 | | | | | | News Article | History of Franklin Resources Inc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Ing Investment Management Co | Institution | 10,730 | Added More | 1,780 | 19.88 % | $102,472 | $93,351 | $-9,121 | -8.90 % | $-1,513 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 595 | Sold Some | -5,555 | -90.32 % | $5,682 | $5,177 | $-506 | -8.90 % | $4,722 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 25,226 | Added More | 2,742 | 12.19 % | $240,908 | $219,466 | $-21,442 | -8.90 % | $-2,331 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 856 | Added More | 58 | 7.26 % | $8,175 | $7,447 | $-728 | -8.90 % | $-49 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Inc | Institution | 1,112 | Added More | 452 | 68.48 % | $10,620 | $9,674 | $-945 | -8.90 % | $-384 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | | Sold All | -1,062 | -100 % | | | | -8.90 % | $903 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Veritable L P | Institution | 13,556 | Added More | 2,704 | 24.91 % | $129,460 | $117,937 | $-11,523 | -8.90 % | $-2,298 | | | | | | News Article | History of Veritable L P Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Baker Bros Advisors Llc | Institution | 636,215 | No Change | 0 | 0 % | $6,063,129 | $5,535,071 | $-528,058 | -8.70 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | J P Morgan Chase And Co | Institution | 53,671 | Added More | 20,142 | 60.07 % | $511,485 | $466,938 | $-44,547 | -8.70 % | $-16,718 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | | Sold All | -20,400 | -100 % | | | | -8.70 % | $16,932 | | | | | | News Article | History of Ubs Ag Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Lee Munder Capital Group Llc | No Data | 100,484 | No Compare | | | $1,001,825 | $874,211 | $-127,615 | -12.73 % | | | | | | | News Article | History of Lee Munder Capital Group Llc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Massachusetts Financial Services Co | Institution | | Sold All | -315,953 | -100 % | | | | -12.73 % | $401,260 | | | | | | News Article | History of Massachusetts Financial Services Co Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Copper Rock Capital Partners Llc | Institution | 352,483 | New Holding | 352,483 | 100 % | $3,542,454 | $3,066,602 | $-475,852 | -13.43 % | $-475,852 | | | | | | News Article | History of Copper Rock Capital Partners Llc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metropolitan Life Insurance Co | Institution | 23,234 | No Change | 0 | 0 % | $233,502 | $202,136 | $-31,366 | -13.43 % | $0 | | | | | | News Article | History of Metropolitan Life Insurance Co Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 22,182 | Sold Some | -886 | -3.84 % | $222,929 | $192,983 | $-29,946 | -13.43 % | $1,196 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 140,181 | Sold Some | -8,000 | -5.39 % | $1,408,819 | $1,219,575 | $-189,244 | -13.43 % | $10,800 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Parametric Portfolio Associates | Institution | 14,863 | Sold Some | -2,404 | -13.92 % | $149,522 | $129,308 | $-20,214 | -13.51 % | $3,269 | | | | | | News Article | History of Parametric Portfolio Associates Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-04 | 2009-08-31 | N-CSRS | Gmo Trust - Gmo Value Fund | Multi-Cap Value | | Sold All | -300 | -100 % | | | | -7.44 % | $210 | | | | | | News Article | History of Gmo Trust - Gmo Value Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-04 | 2009-08-31 | N-CSR | Ssga Funds - Ssga Enhanced Small Cap Fund | Small-Cap Core | 966 | Sold Some | -134 | -12.18 % | $9,080 | $8,404 | $-676 | -7.44 % | $94 | | | | | | News Article | History of Ssga Funds - Ssga Enhanced Small Cap Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Health Care Portfolio | Health/Biotech | 517,160 | Sold Some | -37,500 | -6.76 % | $4,711,328 | $4,499,292 | $-212,036 | -4.50 % | $15,375 | | | | | | News Article | History of Fidelity Select Portfolios - Health Care Portfolio Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Pharmaceuticals Portfolio | Health/Biotech | 10,600 | No Change | 0 | 0 % | $96,566 | $92,220 | $-4,346 | -4.50 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Technology Portfolio | Science & Tech | 312,000 | No Change | 0 | 0 % | $2,842,320 | $2,714,400 | $-127,920 | -4.50 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Technology Portfolio Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Advisor Series I - Dynamic Capital Appreciation Fund | Multi-Cap Growth | | Sold All | -54,288 | -100 % | | | | -3.65 % | $17,915 | | | | | | News Article | History of Fidelity Advisor Series I - Dynamic Capital Appreciation Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Advisor Series I - Equity Value Fund | Multi-Cap Value | 7,900 | New Holding | 7,900 | 100 % | $71,337 | $68,730 | $-2,607 | -3.65 % | $-2,607 | | | | | | News Article | History of Fidelity Advisor Series I - Equity Value Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Advisor Series I - Growth Opportunities Fund | Large-Cap Core | 424,742 | New Holding | 424,742 | 100 % | $3,835,420 | $3,695,255 | $-140,165 | -3.65 % | $-140,165 | | | | | | News Article | History of Fidelity Advisor Series I - Growth Opportunities Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Advisor Series I - Value Strategies | Multi-Cap Core | 376,952 | Added More | 368,070 | 4143.99 % | $3,403,877 | $3,279,482 | $-124,394 | -3.65 % | $-121,463 | | | | | | News Article | History of Fidelity Advisor Series I - Value Strategies Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock | Specialty & Misc | 1,886 | No Compare | | | $17,031 | $16,408 | $-622 | -3.65 % | | | | | | | News Article | History of Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-CSR | Vanguard World Fund - Vanguard Health Care Index Fund | Health/Biotech | | Sold All | -9,828 | -100 % | | | | -3.65 % | $3,243 | | | | | | News Article | History of Vanguard World Fund - Vanguard Health Care Index Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 622,600 | Added More | 2,523 | 0.40 % | $5,715,468 | $5,416,620 | $-298,848 | -5.22 % | $-1,211 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Cornerstone Strategy Fund | Specialty & Misc | | Sold All | -1,500 | -100 % | | | | -5.22 % | $720 | | | | | | News Article | History of Usaa Mutual Funds Trust - Cornerstone Strategy Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | | Sold All | -300 | -100 % | | | | -5.22 % | $144 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Health Sciences Fund | Health/Biotech | 79,400 | New Holding | 79,400 | 100 % | $728,892 | $690,780 | $-38,112 | -5.22 % | $-38,112 | | | | | | News Article | History of Valic Co I - Health Sciences Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Small Cap Index Fund | Small-Cap Core | 19,915 | New Holding | 19,915 | 100 % | $182,820 | $173,261 | $-9,559 | -5.22 % | $-9,559 | | | | | | News Article | History of Valic Co I - Small Cap Index Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Essex Investment Management Co Llc | Institution | 2,761 | No Change | 0 | 0 % | $26,257 | $24,021 | $-2,236 | -8.51 % | $0 | | | | | | News Article | History of Essex Investment Management Co Llc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Advisors Llc | Institution | 371,900 | New Holding | 371,900 | 100 % | $3,771,066 | $3,235,530 | $-535,536 | -14.20 % | $-535,536 | | | | | | News Article | History of Blackrock Advisors Llc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | 35,100 | Added More | 33,926 | 2889.77 % | $355,914 | $305,370 | $-50,544 | -14.20 % | $-48,853 | | | | | | News Article | History of Blackrock Inc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 67,011 | Added More | 28,749 | 75.13 % | $679,492 | $582,996 | $-96,496 | -14.20 % | $-41,399 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Merrill Lynch Mercury Asset Management Japan Ltd | Institution | 2,800 | New Holding | 2,800 | 100 % | $28,392 | $24,360 | $-4,032 | -14.20 % | $-4,032 | | | | | | News Article | History of Merrill Lynch Mercury Asset Management Japan Ltd Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 108,006 | Sold Some | -23,519 | -17.88 % | $1,105,981 | $939,652 | $-166,329 | -15.03 % | $36,219 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | State Board Of Administration Of Florida Retirement System | Institution | 37,520 | Added More | 9,247 | 32.70 % | $384,205 | $326,424 | $-57,781 | -15.03 % | $-14,240 | | | | | | News Article | History of State Board Of Administration Of Florida Retirement System Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Public Employees Retirement Association Of Colorado | Institution | 57,400 | No Change | 0 | 0 % | $586,628 | $499,380 | $-87,248 | -14.87 % | $0 | | | | | | News Article | History of Public Employees Retirement Association Of Colorado Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Public Employees Retirement System Of Ohio | Institution | 30,009 | No Change | 0 | 0 % | $330,399 | $261,078 | $-69,321 | -20.98 % | $0 | | | | | | News Article | History of Public Employees Retirement System Of Ohio Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Dorsey Wright Associates | Institution | 49 | No Change | 0 | 0 % | $554 | $426 | $-128 | -23.07 % | $0 | | | | | | News Article | History of Dorsey Wright Associates Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-08 | 2009-09-30 | 13F-HR | Rhumbline Advisers | Institution | 35,244 | No Change | 0 | 0 % | $400,372 | $306,623 | $-93,749 | -23.41 % | $0 | | | | | | News Article | History of Rhumbline Advisers Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund | Health/Biotech | 27,200 | Added More | 13,600 | 100.00 % | $307,632 | $236,640 | $-70,992 | -23.07 % | $-35,496 | | | | | | News Article | History of Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii - Fidelity Advisor Health Care Fund | Health/Biotech | 273,972 | Added More | 165,303 | 152.11 % | $3,098,623 | $2,383,556 | $-715,067 | -23.07 % | $-431,441 | | | | | | News Article | History of Fidelity Advisor Series Vii - Fidelity Advisor Health Care Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | 300 | New Holding | 300 | 100 % | $3,195 | $2,610 | $-585 | -18.30 % | $-585 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Aim Investment Funds - Aim Developing Markets Fund | Emerging Markets | 475,217 | New Holding | 475,217 | 100 % | $5,217,883 | $4,134,388 | $-1,083,495 | -20.76 % | $-1,083,495 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Core Equity Portfolio | International Small-Mid-Cap Value | 42,617 | Added More | 1,800 | 4.40 % | $467,935 | $370,768 | $-97,167 | -20.76 % | $-4,104 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Core Equity Portfolio Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio | No Data | 10,600 | New Holding | 10,600 | 100 % | $116,388 | $92,220 | $-24,168 | -20.76 % | $-24,168 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio | No Data | 400 | New Holding | 400 | 100 % | $4,392 | $3,480 | $-912 | -20.76 % | $-912 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Advisor Series I - Value Fund | Multi-Cap Value | 5,341 | New Holding | 5,341 | 100 % | $58,644 | $46,467 | $-12,177 | -20.76 % | $-12,177 | | | | | | News Article | History of Fidelity Advisor Series I - Value Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Capital Trust - Fidelity Capital Appreciation Fund | Specialty & Misc | | Sold All | -441,612 | -100 % | | | | -20.76 % | $1,006,875 | | | | | | News Article | History of Fidelity Capital Trust - Fidelity Capital Appreciation Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Commonwealth Trust - Fidelity Large Cap Stock Fund | Large-Cap Core | 13,146 | New Holding | 13,146 | 100 % | $144,343 | $114,370 | $-29,973 | -20.76 % | $-29,973 | | | | | | News Article | History of Fidelity Commonwealth Trust - Fidelity Large Cap Stock Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund | Small-Cap Core | | Sold All | -300 | -100 % | | | | -21.83 % | $729 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund | Small-Cap Core | | Sold All | -600 | -100 % | | | | -21.83 % | $1,458 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange Traded Fund Trust - Powershares Dynamic Small Cap Growth Portfolio | Small-Cap Growth | 11,950 | New Holding | 11,950 | 100 % | $133,004 | $103,965 | $-29,039 | -21.83 % | $-29,039 | | | | | | News Article | History of Powershares Exchange Traded Fund Trust - Powershares Dynamic Small Cap Growth Portfolio Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Direxion Shares Etf Trust - Direxion Daily Small Cap Bull 3x Shares | No Data | | Sold All | -12,563 | -100 % | | | | -22.32 % | $31,408 | | | | | | News Article | History of Direxion Shares Etf Trust - Direxion Daily Small Cap Bull 3x Shares Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Mfs Government Limited Maturity Fund Ma - Mfs Diversified Target Return Fund | No Data | 1,920 | New Holding | 1,920 | 100 % | $21,504 | $16,704 | $-4,800 | -22.32 % | $-4,800 | | | | | | News Article | History of Mfs Government Limited Maturity Fund Ma - Mfs Diversified Target Return Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-17 | 2009-07-31 | N-Q | Rydex Etf Trust - Rydex Inverse Russell 2000 Etf | Specialty & Misc | 530 | New Holding | 530 | 100 % | $5,925 | $4,611 | $-1,314 | -22.18 % | $-1,314 | | | | | | News Article | History of Rydex Etf Trust - Rydex Inverse Russell 2000 Etf Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 1,079,839 | Sold Some | -30,195 | -2.72 % | $11,532,681 | $9,394,599 | $-2,138,081 | -18.53 % | $59,786 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-10 | 2009-06-30 | 13F-HR/A | Veritable L P | Institution | 10,852 | No Change | 0 | 0 % | $120,349 | $94,412 | $-25,936 | -21.55 % | $0 | | | | | | News Article | History of Veritable L P Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-10 | 2009-03-31 | 13F-HR/A | Veritable L P | Institution | 10,852 | No Change | 0 | 0 % | $120,349 | $94,412 | $-25,936 | -21.55 % | $0 | | | | | | News Article | History of Veritable L P Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Jpmorgan Trust Ii - Jpmorgan Technology Fund | Science & Tech | 3 | New Holding | 3 | 100 % | $32 | $26 | $-5 | -17.14 % | $-5 | | | | | | News Article | History of Jpmorgan Trust Ii - Jpmorgan Technology Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Series Funds - Banking Fund | Financial Services | 660 | Added More | 11 | 1.69 % | $6,930 | $5,742 | $-1,188 | -17.14 % | $-20 | | | | | | News Article | History of Rydex Series Funds - Banking Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust - Biotechnology Fund | Health/Biotech | 308 | Added More | 147 | 91.30 % | $3,234 | $2,680 | $-554 | -17.14 % | $-265 | | | | | | News Article | History of Rydex Variable Trust - Biotechnology Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio | Small-Cap Growth | 14,100 | Sold Some | -74,000 | -83.99 % | $146,358 | $122,670 | $-23,688 | -16.18 % | $124,320 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 15,700 | No Change | 0 | 0 % | $162,966 | $136,590 | $-26,376 | -16.18 % | $0 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Value Portfolio | Multi-Cap Value | 4,420 | New Holding | 4,420 | 100 % | $45,880 | $38,454 | $-7,426 | -16.18 % | $-7,426 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Value Portfolio Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqbond Index Portfolio | Specialty & Misc | 42,200 | Added More | 2,000 | 4.97 % | $438,036 | $367,140 | $-70,896 | -16.18 % | $-3,360 | | | | | | News Article | History of Eq Advisors Trust - Eqbond Index Portfolio Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I - Jpmorgan Prime Money Market Fund | Specialty & Misc | 3 | New Holding | 3 | 100 % | $31 | $26 | $-5 | -16.18 % | $-5 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Prime Money Market Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Massmutual Select Funds - Massmutual Select Small Company Growth Fund | Small-Cap Growth | | Sold All | -6,170 | -100 % | | | | -16.18 % | $10,366 | | | | | | News Article | History of Massmutual Select Funds - Massmutual Select Small Company Growth Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 590 | New Holding | 590 | 100 % | $6,124 | $5,133 | $-991 | -16.18 % | $-991 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund Ii - Mml Small Cap Equity Fund | Small-Cap Core | 400 | New Holding | 400 | 100 % | | $3,480 | | - % | | | | | | | News Article | History of Mml Series Investment Fund Ii - Mml Small Cap Equity Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pd Small-Cap Growth Index Portfolio | No Data | 422 | No Compare | | | | $3,671 | | - % | | | | | | | News Article | History of Pacific Select Fund - Pd Small-Cap Growth Index Portfolio Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | Streettracks Series Trust - Spdr Dividend Etf | Specialty & Misc | | Sold All | -4,336 | -100 % | | | | - % | | | | | | | News Article | History of Streettracks Series Trust - Spdr Dividend Etf Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Amvescap Plc | Institution | 646,940 | Sold Some | -669,084 | -50.84 % | $6,443,522 | $5,628,378 | $-815,144 | -12.65 % | $843,046 | | | | | | News Article | History of Amvescap Plc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fmr Corp | Institution | 7,560,566 | Added More | 5,408,026 | 251.23 % | $75,303,237 | $65,776,924 | $-9,526,313 | -12.65 % | $-6,814,113 | | | | | | News Article | History of Fmr Corp Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | N-CSRS | Mfs Variable Insurance Trust - Mfs New Discovery Series | Specialty & Misc | 131,360 | New Holding | 131,360 | 100 % | $1,308,346 | $1,142,832 | $-165,514 | -12.65 % | $-165,514 | | | | | | News Article | History of Mfs Variable Insurance Trust - Mfs New Discovery Series Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Fidelity Central Investment Portfolios Llc - Fidelity Health Care | Health/Biotech | 250,309 | Added More | 72,449 | 40.73 % | $2,730,871 | $2,177,688 | $-553,183 | -20.25 % | $-160,112 | | | | | | News Article | History of Fidelity Central Investment Portfolios Llc - Fidelity Health Care Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Fidelity Magellan Fund - Fidelity Magellan Fund | Large-Cap Growth | 1,000,000 | New Holding | 1,000,000 | 100 % | $10,910,000 | $8,700,000 | $-2,210,000 | -20.25 % | $-2,210,000 | | | | | | News Article | History of Fidelity Magellan Fund - Fidelity Magellan Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Stock Index Fund | Specialty & Misc | 480 | Added More | 380 | 380.00 % | $5,237 | $4,176 | $-1,061 | -20.25 % | $-840 | | | | | | News Article | History of Tiaa Cref Life Fund - Stock Index Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Nasdaq Biotechnology Index Fund | Health/Biotech | 369,779 | Added More | 7,732 | 2.13 % | $4,008,404 | $3,217,077 | $-791,327 | -19.74 % | $-16,546 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Growth Index Fund | Multi-Cap Growth | 173,523 | Sold Some | -7,263 | -4.01 % | $1,880,989 | $1,509,650 | $-371,339 | -19.74 % | $15,543 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Growth Index Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Index Fund | Specialty & Misc | 296,318 | Sold Some | -31,373 | -9.57 % | $3,212,087 | $2,577,967 | $-634,121 | -19.74 % | $67,138 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Index Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | 1,853 | Added More | 324 | 21.19 % | $20,087 | $16,121 | $-3,965 | -19.74 % | $-693 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Growth Index Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Index Fund | Specialty & Misc | 7,889 | Added More | 480 | 6.47 % | $85,517 | $68,634 | $-16,882 | -19.74 % | $-1,027 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Index Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Microcap Index Fund | Specialty & Misc | | Sold All | -22,604 | -100 % | | | | -19.74 % | $48,373 | | | | | | News Article | History of Ishares Trust - Ishares Russell Microcap Index Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Variable Insurance Products Iii - Balanced Portfolio | Flexible Portfolio | 90,455 | Added More | 69,555 | 332.79 % | $980,532 | $786,959 | $-193,574 | -19.74 % | $-148,848 | | | | | | News Article | History of Variable Insurance Products Iii - Balanced Portfolio Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | | Sold All | -3,025 | -100 % | | | | -19.74 % | $6,474 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-28 | 2008-06-30 | N-Q | Vanguard Horizon Funds - Vanguard Strategic Equity Fund | Specialty & Misc | 7,360 | New Holding | 7,360 | 100 % | $79,782 | $64,032 | $-15,750 | -19.74 % | $-15,750 | | | | | | News Article | History of Vanguard Horizon Funds - Vanguard Strategic Equity Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-28 | 2008-06-30 | N-Q | Vanguard Horizon Funds - Vanguard Strategic Small-Cap Equity Fund | Small-Cap Core | 5,700 | New Holding | 5,700 | 100 % | $61,788 | $49,590 | $-12,198 | -19.74 % | $-12,198 | | | | | | News Article | History of Vanguard Horizon Funds - Vanguard Strategic Small-Cap Equity Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Fidelity Trend Fund - Fidelity Trend Fund | Large-Cap Core | 109,500 | Added More | 51,400 | 88.46 % | $1,234,065 | $952,650 | $-281,415 | -22.80 % | $-132,098 | | | | | | News Article | History of Fidelity Trend Fund - Fidelity Trend Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Equity Index Fund | Specialty & Misc | 17,429 | Added More | 12,420 | 247.95 % | $196,425 | $151,632 | $-44,793 | -22.80 % | $-31,919 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Equity Index Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Growth Equity Fund | Multi-Cap Growth | | Sold All | -9,448 | -100 % | | | | -22.80 % | $24,281 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Growth Equity Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Extended Market Index Fund | Mid-Cap Core | 132,552 | New Holding | 132,552 | 100 % | $1,493,861 | $1,153,202 | $-340,659 | -22.80 % | $-340,659 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Extended Market Index Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Growth Index Fund | Large-Cap Growth | 95,709 | New Holding | 95,709 | 100 % | $1,078,640 | $832,668 | $-245,972 | -22.80 % | $-245,972 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Growth Index Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Total Stock Market Index Fund | Multi-Cap Core | 102,240 | New Holding | 102,240 | 100 % | $1,152,245 | $889,488 | $-262,757 | -22.80 % | $-262,757 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Total Stock Market Index Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Value Index Fund | Large-Cap Value | 53,232 | New Holding | 53,232 | 100 % | $599,925 | $463,118 | $-136,806 | -22.80 % | $-136,806 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Value Index Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 600 | No Change | 0 | 0 % | $6,762 | $5,220 | $-1,542 | -22.80 % | $0 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 6,500 | Added More | 5,900 | 983.33 % | $73,255 | $56,550 | $-16,705 | -22.80 % | $-15,163 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-CSRS | Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva | Specialty & Misc | 2,900 | New Holding | 2,900 | 100 % | $31,552 | $25,230 | $-6,322 | -20.03 % | $-6,322 | | | | | | News Article | History of Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva Ownership Of Cadence Pharmaceuticals Inc |
RSS feed for CADX